Brasilicardin A, a new terpenoid antibiotic from pathogenic Nocardia brasiliensis: fermentation, isolation and biological activity. 1999

H Komaki, and A Nemoto, and Y Tanaka, and H Takagi, and K Yazawa, and Y Mikami, and H Shigemori, and J Kobayashi, and A Ando, and Y Nagata
Research Laboratory, Higeta Shoyu Co., Ltd., Choshi, Chiba, Japan.

A novel tricyclic diterpenoid antibiotic, brasilicardin A, was isolated from the culture broth of Nocardia brasiliensis IFM 0406. The antibiotic exhibited immunosuppressive activity in a mouse mixed lymphocyte reaction (MLR) assay system and its IC50 value was 0.057 microg/ml. Although the inhibitory activity of cyclosporin A (CyA) against IL-2 production was confirmed in the MLR assay system, brasilicardin A did not have the activity. The results of in vitro toxicity testing of brasilicardin A against various human cell lines were compared with those of CyA.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009615 Nocardia A genus of gram-positive, aerobic bacteria whose species are widely distributed and are abundant in soil. Some strains are pathogenic opportunists for humans and animals. Micropolyspora
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D005658 Fungi A kingdom of eukaryotic, heterotrophic organisms that live parasitically as saprobes, including MUSHROOMS; YEASTS; smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi, commonly known as molds, refer to those that grow as multicellular colonies. Fungi, Filamentous,Molds,Filamentous Fungi,Filamentous Fungus,Fungus,Fungus, Filamentous,Mold

Related Publications

H Komaki, and A Nemoto, and Y Tanaka, and H Takagi, and K Yazawa, and Y Mikami, and H Shigemori, and J Kobayashi, and A Ando, and Y Nagata
January 2000, The Journal of antibiotics,
H Komaki, and A Nemoto, and Y Tanaka, and H Takagi, and K Yazawa, and Y Mikami, and H Shigemori, and J Kobayashi, and A Ando, and Y Nagata
June 1993, The Journal of antibiotics,
H Komaki, and A Nemoto, and Y Tanaka, and H Takagi, and K Yazawa, and Y Mikami, and H Shigemori, and J Kobayashi, and A Ando, and Y Nagata
January 1978, Zeitschrift fur allgemeine Mikrobiologie,
H Komaki, and A Nemoto, and Y Tanaka, and H Takagi, and K Yazawa, and Y Mikami, and H Shigemori, and J Kobayashi, and A Ando, and Y Nagata
February 1991, The Journal of antibiotics,
H Komaki, and A Nemoto, and Y Tanaka, and H Takagi, and K Yazawa, and Y Mikami, and H Shigemori, and J Kobayashi, and A Ando, and Y Nagata
September 1994, The Journal of antibiotics,
H Komaki, and A Nemoto, and Y Tanaka, and H Takagi, and K Yazawa, and Y Mikami, and H Shigemori, and J Kobayashi, and A Ando, and Y Nagata
November 1993, The Journal of antibiotics,
H Komaki, and A Nemoto, and Y Tanaka, and H Takagi, and K Yazawa, and Y Mikami, and H Shigemori, and J Kobayashi, and A Ando, and Y Nagata
January 1990, The Journal of antibiotics,
H Komaki, and A Nemoto, and Y Tanaka, and H Takagi, and K Yazawa, and Y Mikami, and H Shigemori, and J Kobayashi, and A Ando, and Y Nagata
November 1999, The Journal of antibiotics,
H Komaki, and A Nemoto, and Y Tanaka, and H Takagi, and K Yazawa, and Y Mikami, and H Shigemori, and J Kobayashi, and A Ando, and Y Nagata
September 1960, Revista del Instituto de Salubridad y Enfermedades Tropicales,
H Komaki, and A Nemoto, and Y Tanaka, and H Takagi, and K Yazawa, and Y Mikami, and H Shigemori, and J Kobayashi, and A Ando, and Y Nagata
July 1984, The Journal of antibiotics,
Copied contents to your clipboard!